Repolarization heterogeneity in the right ventricular outflow tract: Correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model

Heart Rhythm

Volumn 5, Issue 5, 2008, Pages 725-733

  Morita, Hiroshi ^a,b   Zipes, Douglas P ^a   Fukushima Kusano, Kengo ^b   Nagase, Satoshi ^b   Nakamura, Kazufumi ^b   Morita, Shiho T ^a,b   Ohe, Tohru ^b   Wu, Jiashin ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Body surface mapping; Optical mapping; QT interval; Repolarization heterogeneity; Ventricular fibrillation

Indexed keywords

PILSICAINIDE;

ADULT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAPHY; ENDOCARDIUM; EPICARDIUM; HEART REPOLARIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; ST SEGMENT ELEVATION; SYNCOPE;

ACTION POTENTIALS; ADULT; ANIMALS; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; DISEASE MODELS, ANIMAL; DOGS; GENETIC HETEROGENEITY; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 42649111652     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.02.028     Document Type: Article

References (30)

1. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
2. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome. Report of the second consensus conference. Heart Rhythm 2 (2005) 429-440
3. Corrado D., Nava A., Buja G., et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 27 (1996) 443-448
4. Shimizu W., Matsuo K., Takagi M., et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 11 (2000) 396-404
5. Hisamatsu K., Kusano K.F., Morita H., et al. Usefulness of body surface mapping to differentiate patients with Brugada syndrome from patients with asymptomatic Brugada syndrome. Acta Med Okayama 58 (2004) 29-35
6. Hisamatsu K., Kusano K.F., Morita H., et al. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps. J Cardiovasc Electrophysiol 15 (2004) 870-876
7. Pitzalis M.V., Anaclerio M., Iacoviello M., et al. QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 42 (2003) 1632-1637
8. Izumida N., Asano Y., Doi S., et al. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome. Int J Cardiol 95 (2004) 261-268
9. Yokokawa M., Takaki H., Noda T., et al. Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome. Pacing Clin Electrophysiol 29 (2006) 1112-1121
10. Morita H., Morita S.T., Nagase S., et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 42 (2003) 1624-1631
11. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100 (1999) 1660-1666
12. Aiba T., Shimizu W., Hidaka I., et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol 47 (2006) 2074-2085
13. Morita H., Zipes D.P., Lopshire J., et al. T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 291 (2006) H421-H428
14. Morita H., Zipes D.P., Morita S.T., et al. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome. Heart Rhythm 4 (2007) 66-74
15. Antzelevitch C., and Di Diego J.M. Role of K+ channel activators in cardiac electrophysiology and arrhythmias. Circulation 85 (1992) 1627-1629
16. Di Diego J.M., and Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry?. Circulation 88 (1993) 1177-1189
17. Fish J.M., and Antzelevitch C. Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1 (2004) 210-217
18. Castro Hevia J., Antzelevitch C., Tornes Barzaga F., et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47 (2006) 1828-1834
19. Kamakura S., Shimizu W., Matsuo K., et al. Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG. Circulation 98 (1998) 1525-1533
20. Flowers N.C., and Horan L.G. Body surface potential mapping. In: Zipes D.P., and Jalife J. (Eds). Cardiac Electrophysiology: From Cell to Bedside. Third Edition (2000), WB Saunders, Philadelphia 737-746
21. Nadeau R., and Savard P. Body surface potential mapping for the localization of ventricular preexcitation sites and ventricular tachycardia breakthroughs. In: Shenasa M., Borggrefe M., and Breithardt G. (Eds). Cardiac Mapping. Second Edition (2003), Futura/Blackwell Publishing, New York 467-481
22. Wu J., Biermann M., Rubart M., et al. Cytochalasin D as excitation-contraction uncoupler for optically mapping action potentials in wedges of ventricular myocardium. J Cardiovasc Electrophysiol 9 (1998) 1336-1347
23. Wu J., and Zipes D.P. Transmural reentry during global acute ischemia and reperfusion in canine ventricular muscle. Am J Physiol Heart Circ Physiol 280 (2001) H2717-H2725
24. Mirvis D.M. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol 5 (1985) 625-631
25. Oster H.S., Taccardi B.T., and Lux R.L. Noninvasive electrocardiographic imaging. Circulation 96 (1997) 1012-1024
26. Ramanathan C., and Rudy Y. Electrocardiographic imaging: II. Effect of torso inhomogeneities on noninvasive reconstruction of epicardial potentials, electrograms, and isochrones. J Cardiovasc Electrophysiol 12 (2001) 241-252
27. Ghanem R.N., Ramanathan C.R., Jia P., et al. Heart-surface reconstruction and ECG electrodes localization using fluoroscopy, epipolar geometry and stereovision: application to noninvasive imaging of cardiac electrical activity. IEEE Trans Med Imaging 10 (2003) 1307-1318
28. Ghanem R.N., Jia P., Ramanathan R., et al. Noninvasive electrocardiographic imaging (ECGI): comparison to intraoperative mapping in patients. Heart Rhythm 2 (2005) 339-354
29. Millar C.K., Kraliios F.A., and Lux R.L. Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions. Circulation 72 (1985) 1372-1379
30. Burgess M.J., Baruffi S., Spaggiari S., et al. Determination of activation and recovery sequences and local repolarization durations from distant electrocardiographic leads. Jpn Heart J 27 Suppl 1 (1986) 205-216